MindMaze Stock

mindmaze.com/Healthcare / Digital HealthFounded: 2012

MindMaze, founded in 2012 by CEO Dr Tej Tadi, is the first Swiss Unicorn with offices in Lausanne, Baltimore, London, Paris and Mumbai, and a global leader in digital neuro-therapeutics (DTx) solutions with a mission to accelerate the brain's ability to recover, learn and adapt. With over a decade of work at the intersection of neuroscience, bio-sensing, engineering, mixed reality and artificial intelligence, its healthcare division is addressing some of the most challenging problems in neurology, including stroke, Alzheimer disease and Parkinson disease, by creating the universal platform for brain health and recovery and unique digital therapeutic interventions.

Register To Buy and Sell Shares

For more details on financing and valuation for MindMaze, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access MindMaze’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like MindMaze.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

MindMaze investors also invested in these private companies

Venture Kick
AlbaCore Capital
Concord Health Partners
Hambro Perks
Hinduja Group
EPFL Innovation Park
MedTech Innovator


Management Team

Tej Tadi Ph.D
Founder & Chief Executive Officer
Kevin Gallagher
Chief Financial Officer
Jea-Marc Wismer
Chief Operating Officer
N.K Chaitanya
Chief Technology Officer
Phoebe Alix
Director of Strategy
Patricia Bradley
Chief Commercial Officer
John Krakauer MD

MindMaze’s stock FAQs


Can you buy MindMaze’s stock?

MindMaze is not publicly traded on NYSE or NASDAQ in the U.S. To buy MindMaze’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell MindMaze’s stock?

Yes, you can sell stock of a private company like MindMaze. Forge can help you sell your MindMaze stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is MindMaze’s stock price?

MindMaze is a privately held company and therefore does not have a public stock price. However, you may access MindMaze’s private market stock price with Forge Data.

What is MindMaze’s stock ticker symbol?

MindMaze does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Babylon will cease trading on NYSE, combine with MindMaze

Digital health firm Babylon is set to go private, combining with digital-neurotherapy firm MindMaze, following a take-private proposal from AlbaCore Capital. The merger will form an AI-driven care platform capable of primary care and disease management. Babylon will cease trading on the NYSE and the deal is expected to close in July.

Babylon Holdings To Be Acquired By AlbaCore Capital, MindMaze Group - Stock Falls

Babylon Holdings is set to be acquired by AlbaCore Capital and MindMaze Group. The deal, expected to close in July 2023, provides $34.5 million in funding to Babylon and significantly reduces the company's debt. The acquisition will combine Babylon's healthcare services with MindMaze's AI capabilities, creating a "digital-first global AI-driven healthcare business."
Updated on: Jul 17, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.